Market news

ACHC shares have doubled YTD as a raised 2026 outlook, stronger cash flow and new facility openings bolster its rebound.

ACHC is converting capacity expansion into stronger cash flow as new facilities mature, patient volumes rise and capital spending stays disciplined.

Acadia Healthcare Company (ACHC) is in focus after management booked a slot at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, drawing fresh attention to the behavioral health operator. Recent trading has been strong for Acadia Healthcare Company, with a 1-day share price return of 2.31% and a 90-day share price return of 15.84% at a latest share price of US$28.81. However, the 3-year total shareholder return has declined 59.12%, showing short term momentum...

Acadia Healthcare Company recently presented at the Jefferies Healthcare Services and Technology Conference on 14 September 2026 at 1 Hotel in Nashville, highlighting its behavioral health operations and outlook. The company emphasized strong underlying demand for mental health and substance use treatment alongside efforts to improve execution and earnings, supported by healthy cash generation and a valuable real estate portfolio. We’ll now examine how Acadia’s focus on execution...

Tenet, Acadia and Community Health Systems have been highlighted in this Industry Outlook article.

Acadia Healthcare (ACHC) has an average rating of overweight and mean price target of $33.57, accord

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 25.7% over the past six months while the S&P 500 was up 13.6%.

FRANKLIN, Tenn., September 09, 2026--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference on September 14th.

Detailed price information for Acadia Healthcr Company (ACHC-Q) from The Globe and Mail including charting and trades.

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Acadia Healthcare's revenue continues to climb, but profitability is pressured by rising labor costs and a tight labor market. Read why ACHC stock is a soft Buy.

Acadia Healthcare is the largest stand-alone behavioral healthcare company in the United States. Find out why ACHC stock is a buy.

Highlighted by clinical facility expansion from Acadia Healthcare and Universal Health Services (UHS), payer integration via Elevance Health (Carelon Behavioral Health), and digital therapy platform growth across BetterHelp (Teladoc Health), Talkspace, Calm, Lyra Health, and Spring Health, the industry is undergoing structural transformation. This study delivers a comprehensive evaluation of 24,696 mental health facilities operated by 14,554 companies, outpatient ($38.2 billion) versus inpatient

Accendra Health (ACH) has an average rating of hold and mean price target of $1.56, according to ana

Acadia Healthcare Company has had a strong year so far, with the share price up 91.4% year to date, while the valuation checks still suggest the stock leans cheap on most measures. The 91.4% year to date gain raises the question of whether recent optimism already captures most of the good news in the price. For a behavioral health operator like Acadia Healthcare Company, expectations for sustainable patient volumes can support the current valuation. However, any pressure on reimbursement...

Shares of behavioral health company Acadia Healthcare (NASDAQ:ACHC) fell 13.3% in the afternoon session after the company reported mixed second-quarter results that overshadowed beats on headline numbers.

Acadia Healthcare's (ACHC) operational turnaround is advancing, with new facilities opening on sched

In the past week, Acadia Healthcare Company, Inc. reported second-quarter 2026 results showing US$865.84 million in sales and a decline in net income to US$10.93 million, while also slightly lifting full-year 2026 revenue guidance to a range of US$3.40 billion to US$3.45 billion. Despite flat year-on-year quarterly revenue and higher liability reserves, the company beat consensus earnings forecasts, generated strong free cash flow, and raised its full-year adjusted EPS outlook, supported by...

ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.

Acadia Healthcare Co Inc (ACHC) surpasses revenue guidance and reduces debt, while facing flat revenue growth and increased liability reserves.

Acadia Healthcare (NASDAQ:ACHC) reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation. Revenue totaled $866 million, unchanged from the prior-year quart

Acadia Healthcare (ACHC) reported Q2 adjusted earnings late Tuesday of $0.38 per diluted share, down

FRANKLIN, Tenn., July 28, 2026--Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026.

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +15.15% and +2.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Behavioral health company Acadia Healthcare (NASDAQ:ACHC) announced better-than-expected revenue in Q2 CY2026, but sales were flat year on year at $865.8 million. The company expects the full year’s revenue to be around $3.43 billion, close to analysts’ estimates. Its non-GAAP profit of $0.38 per share was 9.7% above analysts’ consensus estimates.

Behavioral health company Acadia Healthcare (NASDAQ:ACHC) will be announcing earnings results this Tuesday after the bell. Here’s what you need to know.

What To Expect From Acadia Healthcare’s (ACHC) Q2 Earnings

SAN DIEGO, July 15, 2026--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on August 4, 2026, at 4:30 p.m. Eastern Time.

FRANKLIN, Tenn., July 09, 2026--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Wednesday, July 29, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website, and the archived webcast will be available

Investors need to pay close attention to (Ticker) stock based on the movements in the options market lately.

SAN DIEGO, July 06, 2026--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Carl Segerstrom as Chief People Officer, effective July 6. Carl will lead the company’s global people and culture strategy, supporting its next phase of growth as a leading neurological and rare disease company focused on advancing therapies for patients with significant unmet needs. He will serve as a member of Acadia’s executive leadership team.